Terms: = Liver cancer AND CCND3, P30281, 896, ENSG00000112576 AND Prognosis
20 results:
1. Diagnostic and Prognostic Value of IL-10, FABP2 and LPS Levels in HCC Patients.
Morkunas E; Vaitkeviciute E; Varkalaite G; Pilvinis V; Skieceviciene J; Kupcinskas J
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138294
[TBL] [Abstract] [Full Text] [Related]
2. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics.
Zhang Y; He D; Liu J; Wei YG; Shi LL
World J Gastroenterol; 2023 Apr; 29(13):2001-2014. PubMed ID: 37155523
[TBL] [Abstract] [Full Text] [Related]
3. The Systemic Immune Inflammation Index (SII) Combined with the Creatinine-to-Cystatin C Ratio (Cre/CysC) Predicts Sarcopenia in Patients with liver Cirrhosis Complicated with Primary Hepatocellular Carcinoma.
Lei S; Zhang Q; Zhang Q; Long L; Xiong Y; Sun S; Yuan H; Luo Y; Chen N; Peng H; Luo X
Nutr Cancer; 2023; 75(4):1116-1122. PubMed ID: 36856143
[TBL] [Abstract] [Full Text] [Related]
4. A Novel Diagnostic Model for Early Hepatitis B Virus-Related Hepatocellular Carcinoma Diagnosis.
Li S; Liu D; Wang Q
Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649525
[TBL] [Abstract] [Full Text] [Related]
5. ATP13A2 is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.
Huang J; Xu S; Yu Z; Zheng Y; Yang B; Ou Q
J Gastrointest Surg; 2023 Jan; 27(1):56-66. PubMed ID: 36127552
[TBL] [Abstract] [Full Text] [Related]
6. Application of a Convolutional Neural Network for Multitask Learning to Simultaneously Predict Microvascular Invasion and Vessels that Encapsulate Tumor Clusters in Hepatocellular Carcinoma.
Chu T; Zhao C; Zhang J; Duan K; Li M; Zhang T; Lv S; Liu H; Wei F
Ann Surg Oncol; 2022 Oct; 29(11):6774-6783. PubMed ID: 35754067
[TBL] [Abstract] [Full Text] [Related]
7. Risk of liver Cirrhosis in HBV/HCV-Infected Individuals with First-Degree Relatives Who Have liver cancer: Development and Validation of a Simple Model.
Liu Y; Guo LW; Xu HF; Kang RH; Zheng LY; Zhang LY; Chen Q; Sun XB; Zhang SK; Qiao YL
Cancer Prev Res (Phila); 2022 Feb; 15(2):111-120. PubMed ID: 34675066
[TBL] [Abstract] [Full Text] [Related]
8. Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis.
Chen YS; Hsieh PM; Lin HY; Hung CM; Lo GH; Hsu YC; Lu IC; Lee CY; Wu TC; Yeh JH; Hsiao P; Li YC; Wang YC; Hsieh KC; Lin CW
BMC Gastroenterol; 2021 May; 21(1):220. PubMed ID: 33990184
[TBL] [Abstract] [Full Text] [Related]
9. Diagnostic value of the γ-glutamyltransferase and alanine transaminase ratio, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist II in hepatitis B virus-related hepatocellular carcinoma.
Wang G; Lu X; Du Q; Zhang G; Wang D; Wang Q; Guo X
Sci Rep; 2020 Aug; 10(1):13519. PubMed ID: 32782270
[TBL] [Abstract] [Full Text] [Related]
10. Direct Comparison of Four Presurgical Stratifying Schemes for Prediction of Microvascular Invasion in Hepatocellular Carcinoma by Gadoxetic Acid-Enhanced MRI.
Sun SW; Liu QP; Xu X; Zhu FP; Zhang YD; Liu XS
J Magn Reson Imaging; 2020 Aug; 52(2):433-447. PubMed ID: 31943465
[TBL] [Abstract] [Full Text] [Related]
11. [Clinical characteristics and prognosis of high-risk neuroblastoma with bone marrow metastasis in children].
Fan HJ; Huang C; Su Y; Wang XD; Zhou YC; Duan C; Zhao W; Zhao Q; Jin M; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Nov; 57(11):863-869. PubMed ID: 31665841
[No Abstract] [Full Text] [Related]
12. Rs2303428 of MSH2 Is Associated with Hepatocellular Carcinoma prognosis in a Chinese Population.
Zhu X; Wang Z; Qiu X; Wang W; Bei C; Tan C; Qin L; Ren Y; Tan S
DNA Cell Biol; 2018 Jul; 37(7):634-641. PubMed ID: 29874113
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
[TBL] [Abstract] [Full Text] [Related]
14. Ketone bodies as a predictor of prognosis of hepatocellular carcinoma after transcatheter arterial chemoembolization.
Sasaki R; Taura N; Miyazoe Y; Yamamichi S; Nakashiki S; Yamashima M; Suehiro T; Honda T; Shibata H; Ozawa E; Miuma S; Akazawa Y; Miyaaki H; Matsumoto T; Nakao K; Ashizawa K
Nutrition; 2018 Jun; 50():97-103. PubMed ID: 29549850
[TBL] [Abstract] [Full Text] [Related]
15. Impact of muscle volume and muscle function decline in patients undergoing surgical resection for hepatocellular carcinoma.
Hiraoka A; Otsuka Y; Kawasaki H; Izumoto H; Ueki H; Kitahata S; Aibiki T; Okudaira T; Yamago H; Miyamoto Y; Iwasaki R; Tomida H; Mori K; Miyata H; Tsubouchi E; Kishida M; Hirooka M; Abe M; Matsuura B; Ninomiya T; Mori I; Hiasa Y; Michitaka K
J Gastroenterol Hepatol; 2018 Jun; 33(6):1271-1276. PubMed ID: 29193248
[TBL] [Abstract] [Full Text] [Related]
16. Clinical significance of microRNA 138 and cyclin D3 in hepatocellular carcinoma.
Huang B; Li H; Huang L; Luo C; Zhang Y
J Surg Res; 2015 Feb; 193(2):718-23. PubMed ID: 25439221
[TBL] [Abstract] [Full Text] [Related]
17. Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus.
Berenguer J; Zamora FX; Aldámiz-Echevarría T; Von Wichmann MA; Crespo M; López-Aldeguer J; Carrero A; Montes M; Quereda C; Téllez MJ; Galindo MJ; Sanz J; Santos I; Guardiola JM; Barros C; Ortega E; Pulido F; Rubio R; Mallolas J; Tural C; Jusdado JJ; Pérez G; Díez C; Álvarez-Pellicer J; Esteban H; Bellón JM; González-García J;
Clin Infect Dis; 2015 Mar; 60(6):950-8. PubMed ID: 25422386
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic value of matrix metalloproteinase-1/ proteinase-activated receptor-1 signaling axis in hepatocellular carcinoma.
Liao M; Tong P; Zhao J; Zhang Y; Li Z; Wang J; Feng X; Hu M; Pan Y
Pathol Oncol Res; 2012 Apr; 18(2):397-403. PubMed ID: 21909684
[TBL] [Abstract] [Full Text] [Related]
19. [prognosis analysis of nasopharyngeal carcinoma patients with distant metastasis].
Wang CT; Cao KJ; Li Y; Xie GF; Huang PY
Ai Zheng; 2007 Feb; 26(2):212-5. PubMed ID: 17298756
[TBL] [Abstract] [Full Text] [Related]
20. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
El-Serag HB; Davila JA
Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
[TBL] [Abstract] [Full Text] [Related]
